Drug-target Mendelian randomization analysis supports lowering plasma ANGPTL3, ANGPTL4, and APOC3 levels as strategies for reducing cardiovascular disease risk
Preprint in medRxiv (January 2024)
The most recent citing publications are shown below. View all 65 publications that cite this research output on Dimensions.
Complex effects of sequence variants on lipid levels and coronary artery disease
Article in Cell (September 2023)
Outcome monitoring and risk stratification after cardiac procedure in neonates, infants, children and young adults born with congenital heart disease: protocol for a multicentre prospective cohort study (Children OMACp)
Article in BMJ Open (August 2023)